JAZZ
|
US |
JAZZ PHARMACEUTICALS PLC |
975,000 |
$120M |
7.12% |
8.3%
|
- |
CYTK
|
US |
CYTOKINETICS INC |
2,350,000 |
$111M |
6.55% |
56.7%
|
- |
MRK
|
US |
MERCK & CO. INC. |
800,000 |
$80M |
4.72% |
100.0%
|
- |
ASND
|
US |
ASCENDIS PHARMA A/S - ADR |
520,000 |
$72M |
4.24% |
108.0%
|
- |
RARE
|
US |
ULTRAGENYX PHARMACEUTICAL IN |
1,500,000 |
$63M |
3.74% |
100.0%
|
- |
INSM
|
US |
INSMED INC |
900,000 |
$62M |
3.68% |
-43.8%
|
- |
BMRN
|
US |
BIOMARIN PHARMACEUTICAL INC |
860,000 |
$57M |
3.35% |
115.0%
|
- |
QURE
|
US |
UNIQURE NV |
3,025,000 |
$53M |
3.17% |
-36.3%
|
- |
SLNO
|
US |
SOLENO THERAPEUTICS INC |
1,060,000 |
$48M |
2.82% |
47.2%
|
- |
NUVL
|
US |
NUVALENT INC-A |
600,000 |
$47M |
2.78% |
100.0%
|
- |
GPCR
|
US |
STRUCTURE THERAPEUTICS INC |
1,725,000 |
$47M |
2.77% |
50.0%
|
- |
VERA
|
US |
VERA THERAPEUTICS INC |
1,075,000 |
$45M |
2.70% |
100.0%
|
- |
IMTX
|
US |
IMMATICS NV |
6,275,000 |
$45M |
2.65% |
67.3%
|
- |
KALV
|
US |
KALVISTA PHARMACEUTICALS INC |
4,770,000 |
$40M |
2.40% |
19.3%
|
- |
GERN
|
US |
GERON CORP |
11,000,000 |
$39M |
2.31% |
947.6%
|
- |
ATXS
|
US |
ASTRIA THERAPEUTICS INC |
4,180,000 |
$37M |
2.22% |
4.5%
|
- |
ACLX
|
US |
ARCELLX INC |
475,000 |
$36M |
2.16% |
-29.6%
|
- |
SNY
|
US |
SANOFI-ADR |
750,000 |
$36M |
2.14% |
400.0%
|
- |
GSK
|
US |
GSK PLC-SPON ADR |
1,000,000 |
$34M |
2.01% |
233.3%
|
- |
SVRA
|
US |
SAVARA INC |
10,775,000 |
$33M |
1.96% |
33.2%
|
- |